Director/PDMR Shareholding

RNS Number : 4082Q
GlaxoSmithKline PLC
18 February 2019
 

 

GlaxoSmithKline plc (the 'Company')

 

Transaction notification

 

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr N Hirons

b)

Position/status

SVP, Global Ethics and Compliance

c)

Initial notification/

amendment

Initial Notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882

 

  

 

b)

Nature of the transaction

The exercise of nil-cost options over Ordinary Shares granted on 11 February 2016 under the Company's 2009 Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

£0.0000

15,914 (Deferred)

 

 

£0.0000

9,392 (Matching)

 

 

 

 

 

d)

Aggregated information

 

Aggregated volume Price

25,306

£0.0000

e)

Date of the transaction

2019-02-15

f)

Place of the transaction

 

n/a

 

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

 

a)

Name

Mr N Hirons

 

b)

Position/status

SVP, Global Ethics and Compliance

 

c)

Initial notification/

amendment

Initial Notification

 

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

GlaxoSmithKline plc

 

b)

LEI

5493000HZTVUYLO1D793

 

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

 

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882

 

  

 

b)

Nature of the transaction

The sale of Ordinary Shares to meet tax liabilities on nil-cost options over Ordinary Shares exercised on 15 February 2019 under the Company's Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards.

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

£15.9006

7,500 (Deferred)

 

 

£15.9006

4,425 (Matching)

 

 

 

 

 

d)

Aggregated information

 

 

Aggregated volume

Price

11,925

£15.9006

 

e)

Date of the transaction

2019-02-15

 

f)

Place of the transaction

 

London Stock Exchange (XLON)

 

             

 

 

 

 

 

 

 

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr D Redfern

b)

Position/status

Chief Strategy Officer

c)

Initial notification/

amendment

Initial Notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882

 

  

 

b)

Nature of the transaction

The exercise of nil-cost options over Ordinary Shares granted on 11 February 2016 under the Company's 2009 Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

£0.0000

20,254 (Deferred)

 

 

£0.0000

11,952 (Matching)

 

 

 

 

 

d)

Aggregated information

 

Aggregated volume Price

32,206

£0.0000

e)

Date of the transaction

2019-02-15

f)

Place of the transaction

 

n/a

 

 

 

 

 

 

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

 

a)

Name

Mr D Redfern

 

b)

Position/status

Chief Strategy Officer

 

c)

Initial notification/

amendment

Initial Notification

 

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

GlaxoSmithKline plc

 

b)

LEI

5493000HZTVUYLO1D793

 

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

 

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882

 

  

 

b)

Nature of the transaction

The sale of Ordinary Shares to meet tax liabilities on nil-cost options over Ordinary Shares exercised on 15 February 2019 under the Company's Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards.

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

£15.878

9,545 (Deferred)

 

 

£15.878

5,631 (Matching)

 

 

 

 

 

d)

Aggregated information

 

 

Aggregated volume

Price

15,176

£15.878

 

e)

Date of the transaction

2019-02-15

 

f)

Place of the transaction

 

London Stock Exchange (XLON)

 

             

 

 

 

 

 

 

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Ms C Thomas

b)

Position/status

SVP, Human Resources

c)

Initial notification/

amendment

Initial Notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882

 

  

b)

Nature of the transaction

The exercise of nil-cost options over Ordinary Shares granted on 11 February 2016 under the Company's 2009 Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

£0.0000

29,636 (Deferred)

 

 

£0.0000

17,488 (Matching)

 

 

 

 

 

d)

Aggregated information

 

Aggregated volume Price

47,124

£0.0000

e)

Date of the transaction

2019-02-15

f)

Place of the transaction

 

n/a

 

 

 

 

 

 

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Ms C Thomas

b)

Position/status

SVP, Human Resources

c)

Initial notification/

amendment

Initial Notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882

 

  

b)

Nature of the transaction

The sale of Ordinary Shares to meet tax liabilities on nil-cost options over Ordinary Shares exercised on 15 February 2019 under the Company's Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

£15.8753

13,951 (Deferred)

 

 

£15.8753

8,232 (Matching)

 

 

 

 

 

d)

Aggregated information

 

Aggregated volume Price

22,183

£15.8753

e)

Date of the transaction

2019-02-15

f)

Place of the transaction

 

London Stock Exchange (XLON)

 

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDVLFFKLFFBBF

Companies

GSK (GSK)
UK 100

Latest directors dealings